Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZNF337 Inhibitors

Zinc finger protein 337 (ZNF337) belongs to the zinc finger protein superfamily, which encompasses one of the largest classes of nucleic acid-binding proteins. ZNF337 is characterized by the presence of zinc finger domains, which are small protein structural motifs coordinated by zinc ions. These domains typically contain combinations of cysteine (C) and histidine (H) residues, often referred to as C2H2 zinc fingers, which form a finger-like loop stabilized by the zinc ion.The ZNF337 protein, through its zinc finger domains, is thought to function predominantly as a transcription factor. Transcription factors are integral to the regulation of gene expression, influencing a myriad of biological processes such as development, differentiation, proliferation, and apoptosis. By binding to specific DNA sequences, ZNF337 is presumed to control the transcriptional activity of various genes, serving as a molecular switch to modulate their expression.

While the specific target genes and regulatory pathways of ZNF337 are not fully delineated, zinc finger proteins are generally known to be versatile in their binding capabilities and can regulate diverse sets of genes. Some zinc finger proteins are also known to interact with RNA or mediate protein-protein interactions, expanding their potential functional repertoire.Alterations in ZNF337, like other zinc finger proteins, could have significant biological consequences. Mutations, abnormal expression levels, or dysregulation of such transcription factors can contribute to a range of pathological conditions, including developmental abnormalities and diseases such as cancer.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor, potentially affecting gene expression patterns and indirectly influencing ZNF337 activity.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

A histone deacetylase (HDAC) inhibitor, which may alter chromatin structure and gene expression, potentially impacting ZNF337.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Another HDAC inhibitor, potentially affecting gene regulation and indirectly influencing ZNF337 activity.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$128.00
$505.00
2
(1)

A DNA methyltransferase inhibitor, which can alter gene expression and potentially impact ZNF337.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

Similar to 5-Azacytidine, affects DNA methylation and gene expression, potentially influencing ZNF337.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$88.00
$208.00
24
(2)

A selective HDAC inhibitor, which may have implications for gene regulation involving ZNF337.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$226.00
$846.00
1
(0)

A BET bromodomain inhibitor, potentially influencing gene expression and regulatory mechanisms involving ZNF337.

I-BET 151 Hydrochloride

1300031-49-5 (non HCl Salt)sc-391115
10 mg
$450.00
2
(0)

Another BET bromodomain inhibitor, which can affect transcription regulation, potentially impacting ZNF337.

A-366

1527503-11-2sc-507495
10 mg
$195.00
(0)

A G9a/GLP histone methyltransferase inhibitor, potentially altering epigenetic marks and gene expression relevant to ZNF337.

UNC1999

1431612-23-5sc-475314
5 mg
$142.00
1
(0)

A selective EZH2/EZH1 inhibitor, potentially affecting gene expression patterns relevant to ZNF337.